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The plant Typhonium ﬂagelliforme, commonly known as “rodent tuber” in Malaysia, is often used as a health supplement and
traditional remedy for alternative cancer therapies, including leukemia. This study aimed to evaluate in vitro anti-leukemic activity
of dichloromethane extract/fraction number 7 (DCM/F7) from T. ﬂagelliforme tuber on human T4 lymphoblastoid (CEMss)
cell line. The DCM extract of tuber has been fractionated by column chromatography. The obtained fractions were evaluated
for its cytotoxicity toward CEMss cells as well as human primary blood lymphocytes (PBLs). Assessment of apoptosis produced
by the most active fraction was evaluated by various microscopic techniques and further conﬁrmation of apoptosis was done
by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay. Phytochemical screening was done by gas
chromatography-mass spectrometry (GC-MS). The results shows that 7 out of 12 fractions showed signiﬁcant cytotoxicity against
the selected cell line CEMss, in which fractions DCM/F7, DCM/F11 and DCM/F12 showed exceptional activity with 3, 5 and
6.2μgml −1, respectively. Further studies in the non-cancerous PBL exhibited signiﬁcant selectivity of DCM/F7 compared to
other fractions. Cytological observations showed chromatin condensation, cell shrinkage, abnormalities of cristae, membrane
blebbing,cytoplasmicextrusionsandformationofapoptoticbodiesasconﬁrmedcollectivelybydouble-stainingofacridineorange
(AO)/propidium iodide (PI), SEM and TEM. In addition, DCM/F7 has increased the cellular DNA breaks on treated cells. GC-
MS revealed that DCM/F7 contains linoleic acid, hexadecanoic acid and 9-hexadecanoic acid. The present results indicate that T.
ﬂagelliforme possess a valuable anti-leukemic eﬀect and was able to produce distinctive morphological features of cell death that
corresponds to apoptosis.
1.Introduction
The genus Typhonium gained favorable taxonomic and
pharmacological attention recently. This plant is a member
of the aroid family. The distinguishing feature of aroids is
the occasionally beautiful and often bizarre combination of
spathe and spadix called the inﬂorescenceis, which is used
for trapping their pollinators because of their particular
morphology and organization of their inﬂorescences [1].
Typhonium species are common in Malaysian lowlands,
frequently found in disturbed places [2]. The plant T. ﬂag-
elliforme, commonly known as “rodent tuber” in Malaysia,
is often used as a traditional remedy for alternative cancer
therapies, including leukemia, by various ethnic populations
[3]. This plant is widely distributed in soft, damp and
shady habitats in Southeast Asia, extending even to Northern
AustraliaandSouthIndia[4].Typhoniumﬂagelliformeisnow
commercially available as a healthcare supplement to cure
breast, lung, rectum, liver, prostate, pancreas and cervical
cancers and leukemias [5].
Recently a bioassay-guided approach demonstrated that
several fractions of hexane and DCM extracts of T. ﬂagelli-
forme were found to inhibit the growth of NCI-H23 non-
small cell lung carcinoma cell line signiﬁcantly; however,2 Evidence-Based Complementary and Alternative Medicine
most of these active fractions were also found to inhibit
the growth of non-tumorigenic Bagg Albino (BALB)/c 3T3
mouse ﬁbroblast cell line [4]. A previous study had reported
that the hexane extract of T. ﬂagelliforme displayed poor
cytotoxic activity against in vitro P388 murine leukemia cells
[6]. A low cytotoxic activity has been exhibited by the polar
fraction of this plant in vitro [7]a n df o u n dt op r o v i d er e l i e f
incoughandasthma[8].Pharmacologicalstudiesconducted
on rats also indicated that T. ﬂagelliforme juice extract could
prevent hepatocarcinogenesis [4].
Plants as natural products are valuable sources of bioac-
tive compounds and have been used in almost all cultures
and communities for thousands of years [9]. Previous phy-
tochemical studies with the T. ﬂagelliforme revealed several
chemical constituents. The hexane extract was reported to
containsaturatedhydrocarbonsandaliphaticacids[7],while
the ethyl acetate extract was found to contain aromatic fatty
acids [10], the DCM extract of whole plants exhibits the
presence of hexadecanoic acid, 1-hexadecene, phytol and a
derivative of phytol [4]. In addition, phenylpropanoid gly-
cosides, sterols and a cerebroside which has anti-hepatotoxic
activity were also reported from the root of this plant [11].
Alternative medicines are used widely all over the world
[12, 13]. Some natural plants are currently being used
extensively as food and health supplements, which help to
combat cancer/tumor and stimulate immunity. In any case,
the use of complementary and alternative medicines has
not been as popular in modern medicine until recently.
This may be most probably due to the lack of enough
biological evidence stating their functional mechanisms.
But for the past few decades, the value of complementary
and alternative medicine (CAM) has been rediscovered by
many modern scientiﬁc researchers, and numerous studies
have established the potential use of herbal preparations
[14, 15]. However, much study is needed to understand
further the use of alternative therapy, including healthcare
food supplements (vitamins, antioxidants and fatty acids)
and herbal preparation in treating cancer, particularly the
beneﬁts and risks in using such edible plant therapy for
treatment. There is very little literature available on the
mechanism of T. ﬂagelliforme and its eﬀects on other cancers.
In this study, we aimed to establish the relation between this
plant and its anticancer eﬀect toward leukemia, in regard
to its mechanism of cell death and possible phytochemicals
present.
2. Methods
2.1. Plant Materials. Typhonium ﬂagelliforme (Lodd.) Blume
(Araceae) whole plant (leaves and tubers) were collected in
July 2008 from the state of Selangor, Malaysia. Authentica-
tion was done at the Faculty of Science, University Putra
Malaysia, where the voucher specimen TF-TL100156 was
deposited.
2.2. Extraction of T. ﬂagelliforme Tuber. Fresh plants were
harvested and washed thoroughly with running tap water
and then distilled water, followed by tubers being separated
Table 1: The yield and growth-inhibitory activity of fractions
obtained from DCM extracts of T. ﬂagelliforme.
Fractions Percentage yield
value (w/w)
IC50 (μgm l −1,
mean ± SEM)
DCM/F1 5.45 >25
DCM/F2 1.95 >25
DCM/F3 4.6 22 ± 1.02
DCM/F4 3.05 9 ± 0.44
DCM/F5 2.3 16 ± 0.9
DCM/F6 9.85 >25
DCM/F7 10.15 3 ± 0.08
DCM/F8 4.25 21 ± 1.3
DCM/F9 4.98 >25
DCM/F10 4.89 >25
DCM/F11 7.4 5 ± 0.32
DCM/F12 9.65 6.2 ± 0.61
The IC50 are average values of three independent triplicate assays.
from aerial parts prior to drying. The tubers were air
dried and then oven dried (Memmert, model 100-800,
Schwabach, Germany) at lower temperature. The fully dried
tubers were powdered and weighed prior to cold maceration.
The powdered tubers were then extracted with hexane
to remove the non-polar fractions and then treated with
DCM. The DCM extraction was done for 7 days with
occasional shaking (Edmund Buchler shaker, Model KS-15,
Hechingen, Germany) and the process was repeated 3 times.
The combined extracts were ﬁltered through Whatman No.
41 ﬁlterpaper (pore size: 20–25μm) and vacuumdried using
a rotary evaporator (Buchi, R-210, Postfach, Switzerland)
andweighedtocalculatetheyieldoftheextracts.Theextracts
were kept at 4◦C until further requirement.
2.3. Fractionation of the DCM Extract. The DCM extract
(2g) from T. ﬂagelliforme tuber was fractionated by vacuum
liquid chromatography (VLC). The stationary phase was
made up of glass column packed with silica gel 60 PF254
with gypsum (Merck, Darmstadt, Germany). The mobile
phase consisted of combinations of hexane, ethyl acetate
and methanol and the eluting strength of the solvent was
increased gradually by increasing the composition of a more
polar solvent. For the puriﬁcation of extract, the initial
solvent composition was hexane-ethyl acetate (9:1 v/v;
1000ml), which was then changed to hexane-ethyl acetate
(7:3 v/v; 1000ml), followed by hexane-ethyl acetate (1:1
v/v; 1000ml), ethyl acetate (500ml) and ﬁnally methanol
(500ml). The eluent was collected in fractions of 100 ml.
The chemical composition of each fraction was evaluated
using thin-layer chromatography (TLC) and visualized with
ultraviolet (UV) light (254nm and 365nm). Based on the
TLC proﬁles, those fractions with similar compositions were
pooled together and concentrated under reduced pressure. A
total of 12 combined fractions were obtained and designated
asDCM/F1,DCM/F2,...,DCM/F12.Theyieldvalueofeach
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2.4. Cell Viability Assay. Human T4-lymphoblastoid cell line
CEMss was provided from the National Institutes of Health
(NIH) AIDS Research and Reference Reagent Program,
Division of AIDS, NIAID, NIH: USA, and was used in this
study(OrderNo:20081911).Thecellsuspension(0.1million
cells ml−1) was plated out into 96-well microtiter plates.
All the 12 fractions were dissolved with dimethylsulfoxide
(DMSO) and the ﬁnal concentration of DMSO was 0.1%
(v/v). Diﬀerent concentrations of the sample were prepared
with serial dilution. Dimethylsulfoxide (0.1%) was used as a
control.
The toxicity proﬁles of the fraction were assessed using
the 3-[4, 5-dimethylthiazol-2-yl]-2, 5-diphenyltetrazolium
bromide (MTT) microculture tetrazolium viability assay
[16]. Thereafter, the various concentrations of samples were
plated out in triplicates. Each plate included untreated
cell controls and a blank cell-free control. After 68 h of
incubation,MTT(5mgml−1)wasaddedtoeachwellandthe
plates incubated for a further 4h and the media removed.
DMSO was later added into each well to solubilize the
formazan crystals. The absorbance was read at a wavelength
of 595nm using a microtiter plate reader (Tecan Sunrise
basic, Groedig, Austria).The percentage cellular viability
was calculated with the appropriate controls taken into
account. The concentration which inhibited 50% of cellular
growth (IC50 value) was determined. All experiments for
each extract were carried out in triplicates. The inhibitory
rate of cell proliferation was calculated by the following
formula: growth inhibition = OD control − OD treated/OD
control × 100. The cytotoxicity of the sample on cancer
cells was expressed as IC50 values (the drug concentration
reducing the absorbance of treated cells by 50% with respect
to untreated cells).
2.5. The Eﬀect of Selected Fractions on Stimulated (Prolifer-
ated) Primary Human Blood Lymphocytes. Since the crude
DCM extract exhibited an IC50 value of 6μgml −1, those
fractions of the DCM extract that showed IC50 value below
this concentration were used in a study toward normal
cells, as described previously by Shaun et al. [17]w i t h
minor modiﬁcations. Hence to compare the eﬀects of the
selected fractions, DCM/F7, DCM/F11 and DCM/F12 on
the leukemic (CEMss) cells to its eﬀects on equivalent
non-cancer cells, their impact on primary human blood
lymphocytes (PBLs) was then investigated. Centrifuge tubes
(size: 25ml) were ﬁlled with 10 ml lymphocyte separation
medium (PAA, Pasching, Austria). Undiluted heparinized
whole blood was then carefully poured over the lymphocyte-
separation solution. The separation process was performed
by centrifugation at 1200 × g for 20min. The lymphocytes
(70–100% enrichment) were concentrated in the inter-
phase (white layer) between the plasma and the separa-
tion solution. They were subsequently extracted carefully
using a sterile Pasteur pipette and washed twice in culture
medium. The culture media used was Quantum PBL media
containing 10% Fetal Bovine Serum (FBS) supplemented
with 100Uml−1 penicillin, 100μgml −1 streptomycin and
phytohemagglutinin(PHA)10mM(PAA,Pasching,Austria)
at 37◦C in a 5% carbon dioxide (CO2)a t m o s p h e r e .F l a s k s
were seeded with 1 × 106 of cells and treated by fractions
with the respective IC50 concentration toward the CEMss
cells for 72h. A negative control of 0.1% v/v DMSO was
used. Three independent separate experiments were carried
out for each exposure. After 72h of exposure, cells were
harvested followed by testing for the evidence of cytotoxicity
toward lymphocytes cells which was carried out by Trypan
blue exclusion assay. The trypan blue exclusion assay detects
only dead cells with damaged cell membrane (necrotic cells),
since trypan blue does not penetrate into living cells [18].
2.6. Identiﬁcation and Chemical Analysis of Bioactive Fraction
Using GC-MS. The bioactive DCM/F7 was analyzed by
ShimadzuGC-MSGC-17A.ABP-X5capillarycolumn(30m
0.25mm I.D. 0.25lm ﬁlm thickness) was used for gas
chromatographic separation of the analytes. The injection
volume was 1μl with a split ratio of 25:1; the injector tem-
perature was held constant at 250◦C. Helium was used as the
carrier gas with an inlet pressure of 46.9kPa, corresponding
to a ﬂow rate of 1.0mlmin−1. The column oven temperature
wassetat35◦C(heldfor3min),raisedat8◦Cmin −1 to280◦C
( h e l df o r3m i n )a n dﬁ n a l l yh e l da t3 0 0 ◦C for 15min. The
mass spectrometer was operated in the electron impact (EI)
mode with ionization energy of 70eV. The transfer line was
set at 290◦C. The chemical constituents of the analyte were
identiﬁed by comparing the MS fragmentation patterns with
those of NIST/EPA/NIH mass special database library of the
GC-MS system.
2.7. Microscopic Observation of Cellular Morphology Using
Phase-Contrast Inverted Microscope. This analysis examines
whether apoptosis may be implicated in mediating cell death
among CEMss cells elicited by fractions of T. ﬂagelliforme
tuber. The DCM/F7 was chosen in this analysis, since this
fraction showed the lowest IC50 with higher selectivity
compared with other fractions. Morphological appearance
o ft r e a t e dc e l l sw a sc o m p a r e dw i t ht h eu n t r e a t e dc o n t r o lb y
using the normal inverted microscope. The morphological
changes of the cells were observed under the normal inverted
microscope post treatment [19]. The IC50 value of the
DCM/F7 was subsequently used in this study. Human T4-
lymphoblastoid cell line (CEMss) were treated with the
fractionfor48and72h.Untreatedcellsservedasthenegative
control.
2.8. Quantiﬁcation of Apoptosis Using Propidium Iodide
andAcridineOrangeDouble-Staining. DCM/F7-induced cell
death in CEMss leukemia cells was quantiﬁed using propid-
ium iodide (PI) and acridine orange (AO) double-staining
according to standard procedures and examined under ﬂuo-
rescencemicroscope(LiecaattachedwithQ-FloroSoftware).
Brieﬂy, treatment was carried out in a 25ml culture ﬂask
(Nunc, Roskilde, Denmark). CEMss cells were plated at
concentration of 1 × 106 cell ml−1 and treated with DCM/F7
at IC50 concentration. Flasks were incubated in atmosphere
of 5% CO2 at 37◦C for 24 and 48h. The cells were then spin
down at 300 × g for 10min. Supernatant was discarded and
the cells were washed twice using phosphate buﬀered saline4 Evidence-Based Complementary and Alternative Medicine
(PBS) after centrifuging at 300 × gf o r1 0 m i nt or e m o v e
the remaining media. Ten microliters of ﬂuorescent dyes
containing AO (10μgml −1)a n dP I( 1 0μgml −1)w e r ea d d e d
into the cellular pellet at equal volumes. Freshly stained cell
suspension was dropped into a glass slide and covered by
a cover slip. Slides were observed under UV-ﬂuorescence
microscope within 30min before the ﬂuorescent color starts
to fade. The percentages of viable, early apoptotic, late
apoptosis and secondary necrotic cells were determined in
>200 cells. AO and PI are intercalating nucleic acid-speciﬁc
ﬂuorochromes which emit green and orange ﬂuorescence,
respectively, when they are bound to DNA. Of the two, only
AO can cross the plasma membrane of viable and early
apoptotic cells. The criteria for identiﬁcation are as follows:
(i) viable cells appear to have green nucleus with intact
structure; (ii) early apoptosis exhibit a bright-green nucleus
showing condensation of chromatin in the nucleus; (iii)
dense orange areas of chromatin condensation showing late
apoptosis and (iv) orange intact nucleus depicting secondary
necrosis [20]. This assay provides a useful quantitative
evaluation and was done in triplicates (n = 3).
2.9. Exterior Ultrastructural Eﬀects of DCM/F7 on CEMss
Cells (SEM). CEMss cells were cultured with the IC50 of
DCM/F7 and incubated for 24 and 48 h. The cancer cells
were centrifuged for 10min at 500 × g. The pellets were
ﬁxed in 4% (v/v) glutaraldehyde in 0.1M coccadylate buﬀer
(pH: 7.4) for 4h, 4◦C. The ﬁxed cells were washed in three
changes of sodium coccadylate buﬀer for 10min each, post-
ﬁxed in 1% osmium tetraoxide at 4◦C. The specimens were
then washed in three changes of sodium coccadylate buﬀer
(pH: 7.4) for 10min each, dehydrated in ascending grades of
acetone (35, 50, 75, 95 and 100%), and brought to critical
point of drying by the critical point drier (CPD 030, Bal-
TEC,Balzer,Switzerland)for30min.Thecellswereaﬃxed to
a metal SEM stub and sputter-coated in gold by using SEM
coating unit (E5100 Polaron, west Sussex, UK). The coated
specimens were viewed using scanning electron microscope
(JOEL 64000, Tokyo, Japan) at accelerating voltage of 15–
25kV.
2.10. Transmission Ultrastructural Eﬀects of DCM/F7 on
CEMss Cells (TEM). CEMss cells were cultured with the
IC50 of DCM/F7 and incubated for 24 and 48h at 37◦C.
The cultured cells were harvested and centrifuged for 10min
at 500 × g at room temperature. The pellets were ﬁxed in
4% (v/v) glutaraldehyde in 0.1M coccadylate buﬀer (pH
7.4) for 4h at 4◦C. The ﬁxed cells were centrifuged, and
the pellets were blocked in serum which was later ﬁxed in
glutaraldeyde overnight at 4◦C. The specimens were washed
in three changes of sodium coccadylate buﬀer (pH 7.4) for
10 min each, post-ﬁxed in 1% osmium tetraoxide at 4◦C.
The specimens were then washed in three changes of sodium
coccadylate buﬀer (pH: 7.4) for 10min each and dehydrated
with a graded series of acetone (35, 50, 75, 95 and 100%).
The cells were then inﬁltrated with acetone and resin and
embedded with 100% resin in beam capsule, and left to
polymerize at 60◦C for 48h. The area of interest in the
embedded cells resin block was chosen using the toulidine
blue staining and later examined using light microscope.
The selected area was cut in ultrathin sections using an
ultra microtome. The sections were placed into a grid and
stained with uranyl acetate for 10min followed by 50%
ﬁltered acetone, and ﬁnally stained using lead which was
then washed twice with distilled water. The stained samples
were then viewed under transmission electron microscope
(Phillips, Eindhoven, The Netherlands).
2.11. ApoBrdU-Terminal Deoxynucleotidyl Transferase dUTP
N i c kE n dL a b e l i n gA s s a y . The induction of apoptosis follow-
ing incubation of DCM/F7 on CEMss cells was evaluated
with the terminal deoxynucleotidyl transferase dUTP nick
end labeling (TUNEL) assay according to the manufacturer’s
protocol (APO-BRDU kit, Sigma, St Louis, Missouri.).
Brieﬂy, about 1 × 106 exponentially growing cells were
seeded and treated with the DCM/F7 for 12, 24 and 48h.
The cultured cells were harvested and, following two washes
in 1ml of PBS, cells were ﬁxed in 1% paraformaldehyde in
PBS and placed on ice for 15min and then ﬁxed with 5 ml
of 70% (v/v) ethanol on ice for 30min. Following washing
in cold-wash buﬀer (APO-BRDU kit, Sigma), cells were
incubated for 60min at 37◦Ci nat e m p e r a t u r e - c o n t r o l l e d
bath with occasional shaking in the freshly prepared DNA-
labeling solution (APO-BRDU kit, Sigma) containing Br-
dUTP and TdT enzyme. At the end of the incubation,
cells were rinsed twice with rinsing buﬀer (APO-BRDU kit,
Sigma), later incubated for 30min at room temperature in
the dark with 0.1ml of the antibody solution containing
anti-BrdUFITC monoclonal antibody. Following incubation
with the antibody, a solution of PI/RNase was added to the
cell suspension for 30min at room temperature in the dark.
Cells were then analyzed by a Dako ﬂow cytometer equipped
with an Argon laser (Cyan ADP, Dako, Denmark), where the
analysis was performed using Summit V4.3 software.
2.12. Statistical Analysis. Results were reported as mean ±
SD for at least three analyses for each sample. Normality
andhomogeneityofvarianceassumptionswerechecked.Sta-
tistical analyses were performed according to the Statistical
Package for Social Sciences, Version 16 (SPSS-16.0) package.
Analyses of variance were performed using the Analysis of
Variance (ANOVA) procedure. The Pearson chi-square test
was used to analyze the data of the comparison of selectivity
of diﬀerent fractions on PBL. Signiﬁcant diﬀerences (P <
.05) between the means were determined using Duncan’s
multiple-range tests.
3. Results
3.1. In Vitro Cytotoxicity against CEMss and Stimulated
Primary Human Blood Lymphocytes. Fractionation of the
DCM extract of the plant tuber by vacuum liquid column
chromatography yielded a total of 12 fractions. A total of 7
outof12fractionsshowedsigniﬁcantcytotoxicityagainstthe
selected cells line, CEMss (Table 1). The MTT results showed
that fractions DCM/F7, DCM/F11 and DCM/F12 exhibitedEvidence-Based Complementary and Alternative Medicine 5
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Figure 1: Inhibition eﬀects of selected fraction (DCM/F7,
DCM/F11 and DCM/F12) on proliferated human peripheral blood
lymphocytes. Results are means ± SD for n = 3.
exceptional activity with 3, 5 and 6.2μgml −1,r e s p e c t i v e l y ,
whichwasbelowthecytotoxicitylevelofcrudeDCMextract.
Comparatively, 5-ﬂuorouracil, a drug with antineoplastic
activitywasusedinthisstudy.5-ﬂuorouracilisusedwidelyin
thetreatmentofleukemiaanditimposed aninhibitory eﬀect
on CEMss cells with an IC50 value of 1.43 ± 0.06μgml −1.
In order to further evaluate the mechanistic study of the
fractions, we compared the cytotoxicty of DCM/F7 against
DCM/F11 and DCM/F12 on non-tumorigenic cells (human
PBL). Interestingly, in contrast to the eﬀects of 3μgml −1
DCM/F7 on CEMss, which killed half of the cell population
within 72h, there was no evidence of signiﬁcant cytotoxicity
on human PBL. DCM/F7, furthermore, exhibited very less
cytotoxicity on human PBL, compared to the other two
fractions (Figure 1).
3.2. Quantiﬁcation of Apoptosis Using Phase-Contrast Micros-
copy and Propidium Iodide and Acridine Orange Double-
Staining. Normal inverted microscopy was carried out to
observe any morphological changes occuring in the cells
treated with DCM/F7, which was well compared with
untreated cells. Figures 2(a)–2(c) showed several morpho-
logical changes of treated and untreated cells at 72h post
treatment under ×400 magniﬁcation. The treated cells
showed obvious changes as compared to untreated cells.
Treated CEMss cells showed blebbing of the cell membrane,
a more prominent growth inhibition and shrinkage of the
cells. On the contrary, untreated cells remained conﬂuent
throughout the incubation period.
Moreover, treated CEMss cells were scored under ﬂuores-
cencemicroscopeinordertoquantifyviable,earlyapoptosis,
late apoptotic and secondary necrosis. We counted 200 cells
arbitrarily and diﬀerentially, together with the untreated
negative control. The study revealed that DCM/F7 triggered
morphological features that relate to apoptosis in a time-
dependent manner (Figures 3(a)–3(d)). Early apoptosis was
obvious by intercalated AO within the fragmented DNA.
In several of such cases, the ﬂuorescent bright-green color
could be seen in treated CEMss cells only. In contrast,
untreated cells were observed with a green intact nuclear
structure. At 24 h treatment with DCM/F7, blebbing and
nuclear chromatin condensation were noticed (moderate
apoptosis). In addition, in the late stages of apoptosis,
changes such as presence of reddish-orange color due to
the binding of AO to denatured DNA were observed after
48h of treatment. Diﬀerential scoring of treated CEMss cells
(200 cells population) showed that there is a statistically
signiﬁcant (P < .05) diﬀerence in apoptosis-positive cells,
which indicates clearly that a time-dependent apoptogenic
eﬀect has occurred. On the other hand, there was no
statistically signiﬁcant (P > .05) diﬀerence in necrotic counts
at diﬀerent treatment times (Figure 4).
3.3. Ultramorphological Apoptotic Observations Were Seen
in DCM/F7-Treated CEMss Cells. Morphological analysis
of treated CEMss cells was carried out to gain insight
into morphological alteration caused by DCM/F7. Both
extra- and intracellular structure analysis was carried out
by SEM and TEM, respectively. Interpretation of SEM elec-
tromicrographs showed distinctive morphological changes
corresponding to a typical cellular surface morphology of
apoptosis, including cell shrinkage, membrane blebbing and
formation of apoptotic bodies (Figures 5(b) and 5(c)). The
intramorphological features observed by TEM demonstrated
a clear morphological change in the nucleus with the
formation of sharply, uniformly and ﬁnely granular masses,
which marginated against the nuclear envelope (Figures
6(b) and 6(c)). The presence of partly degraded apoptotic
bodies around the cells cytoplasm was also evident. All these
morphological and ultrastructural changes attributed to the
incubation of CEMss cells with 3μgml −1 DCM/F7 for 24
and 48h are characteristics associated with apoptosis. On
the contrary, untreated CEMss cells showed well-preserved
morphology and cell organelles Figures 5(a) and 6(a).
These apoptotic eﬀects were found to be time correlated
phenomena and this was noticed when considering the
number of blebs formation (cytoplasmic extension) as an
indicator of cell death via apoptosis.
3.4. ApoBrdU-TUNEL Assay. The biochemical hallmark of
apoptosis is the internucleosomal degradation of cellular
DNA by an endonuclease, and this results in the appearance
of DNA fragments. In order to detect free 3 -OH ends in
the DNA fragments, the TUNEL assay method was used
and thus apoptotic cells can be identiﬁed. The percentages
of apoptotic cells determined after DCM/F7 treatments are
shown in Figure 7. The signiﬁcant increase in the number of
apoptotic cells with fragmented DNA was observed after the
treatment when DCM/F7 was used at the concentration of
3 μgm l −1 for 12, 24 and 48h. In addition, signiﬁcant time-
dependentincreaseoffragmentedDNAwasobservedateach
time point. Our results demonstrated that the number of
apoptotic cells increases after 12h post treatment (Table 2).
3.5. Identiﬁcation and Chemical Analysis of Bioactive Fraction
Using GC-MS. Table 3 shows the analysis of the DCM/F7
by GC-MS, which revealed a total of 40 compounds and
hesitantly identiﬁed 30 compounds including linoleic acid,
n-hexadecanoic acid, 9 hexadecanoic acid and stigmasta-
5,22-dien-3-ol. The unsaturated omega-6 fatty acid, linoleic6 Evidence-Based Complementary and Alternative Medicine
50µm
(a)
50µm
BL
(b)
50µm
BL
AP
(c)
Figure 2: Normal contrast micrographs of CEMss treated at IC50 of DCM/F7 in a time-dependent manner. Concentration for 24hrs (b)
and 48hrs (c) compared with untreated cancer cell (a) (400x magniﬁcation). AP: apoptotic cell; BL: blebbing of the cell membrane.
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Figure 3: Fluorescent micrographs of acridine orange and propidium iodide double-stained human T4 lymphoblastoid cells (CEMss).
CEMss were treated at IC50 of DCM/F7 in a time-dependent manner. Cells were cultured in RPMI 1640 media maintained at 37◦Ca n d5 %
CO2. (a) Untreated cells after 48 hr showed normal structure without prominent apoptosis and necrosis. (b) Early apoptosis features were
seen after 24 hours representing intercalated acridine orange (bright green) amongst the fragmented DNA, (c, d) Blebbing and orange color
representing the hallmark of late apoptosis were noticed in 48-h treatment (magniﬁcation 400x). VI: Viable cells; BL: blebbing of the cell
membrane; CC: Chromatin condensation; LA: Late apoptosis.Evidence-Based Complementary and Alternative Medicine 7
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Figure 4: Percentages of viable, early apoptotic, late apoptosis and
secondary necrotic cells after DCM/F7 treatment. CEMss cell death
viaapoptosisincreasedsigniﬁcantly(∗P<. 05)inatime-dependent
manner. However, no signiﬁcant (P>. 05) diﬀerence was observed
in the cell count of necrosis. Cells were cultured in RPMI 1640
(25ml ﬂask) media maintained at 37◦Ca n d5 %C O 2.E A :E a r l y
apoptosis; LA: Late apoptosis; SN: Secondary necrosis.
Table 2: Apo Brdu-TUNEL assay of CEMss cells.
Percentage of cells (%)
Control Treatment
12 h 24 h 48 h
Non-apoptotic 98.47 ± 6.2 94.85 ± 6.3 78.96 ± 5.5 71.29 ± 5.9
Apoptotic 1.77 ± 0.2 6.53 ± 0.5 23.05 ± 1.9 29.3 ± 2.1
Apo Brdu-TUNEL assay showing the eﬀect of 48h exposure of CEMss to
3μgml −1 DCM/F7. The table shows the eﬀect of control, 12, 24 and 48 h
post-treatment TUNEL positive and TUNEL negative cells. ±SD are from
two independent experiments.
acid was present in large amounts (51.2%) in DCM/F7
followed by n-hexadecanoic acid (17.89%), 9-hexadecanoic
acid (6.99%) and stigmasta-5,22-dien-3-ol (6.06%).
4. Discussion
Cancer is the second leading cause of death in the world. The
prognosis for a patient with metastatic carcinoma remains a
concern and accounts for more than one half of all cancer
deaths. Almost all artiﬁcial agents currently being used in
cancer therapy are known to be toxic and they cause severe
damage to normal cells. Therefore, chemoprevention or
chemotherapy via nontoxic agents and food supplements
could be one approach for decreasing the incidence of these
cancers [21]. Recently, CAM has directed its interest toward
remedy for vital ailment worldwide [22], which includes
herbalmedicine[23].Naturallyoccurringcompoundsfound
in food and medicinal plants could, in theory, serve as
alternatives to chemically designed anticancer agents [24]
and this kind of drug discovery is relevant to CAM [25].
The eﬀect of T. ﬂagelliforme h a sb e e ns t u d i e do nh u m a n
cancer cell lines and in murine P388 [4, 5, 7]. Our results
show that this plant has potent cytotoxicity and anticancer
potential through inducing apoptosis in CEMss cells. The
DCM/F7 showed a concentration-dependent inhibition of
cell growth of the CEMss cell line, which was established
by MTT assay. The MTT is a standard colorimetric assay
(an assay which measures changes in color) for measuring
cellular growth. The American National Cancer Institute
guidelines set the limit of activity for crude extracts at a
50% inhibition (IC50)o fp r o l i f e r a t i o no f<30μgml −1 after
an exposure time of 72h [26]. Therefore, the DCM fractions
as well the maximum concentration used in this study
were <30μgml −1. The MTT results showed that fractions
DCM/F7, DCM/F11 and DCM/F12 exhibited exceptional
activity with 3, 5 and 6.2μgml −1,r e s p e c t i v e l y ,w h i c hw a s
below the cytotoxicity level of crude DCM extract. It is
critical for an anticancer agent to exhibit high cytotoxicity
but such activity should be speciﬁc for the cancer cells
only. The results obtained from this current investigation
indicated that CEMss cells were far more sensitive to the
cytotoxic action of DCM/F7 compared to the PBLs. These
results were consistent with previous studies, which reported
that the fraction obtained from the DCM extract of T.
ﬂagelliformeshowedcytotoxicactivitytowardNCI-H23cells,
but not to noncancerous BALB/c 3T3 cells [4].
The morphological observation revealed that both extra-
and intracellular structures were intensely aﬀected following
DCM/F7 treatment. Until today, the microscopic exami-
nation has been the gold standard for the most precise
detection of apoptosis [27]. With this technique the whole
p r o c e s so fa p o p t o s i sc a nb eo b s e r v e da n de v a l u a t e db a s e d
on the original morphological criteria [28]. Apoptosis was
originally deﬁned by structural alterations in cells observable
by various microscopic techniques [29]. The reduction of
number of viable cells in the treatment was in accordance
with its cytotoxicity property showed the plant fraction.
Clear signs of apoptosis, such as cytoplasmic shrinkage
and membrane blebbing, were observed by phase contrast
microscopy. Moreover, using the properties of AO and PI,
CEMss cells were treated with DCM/F7 to determine its
antiproliferative and apoptogenic characters. The antipro-
liferative properties of DCM/F7 could be then evaluated
by counting the number of viable cancer cells, while the
apoptogenic were determined through observing typical
morphological changes of apoptosis. In the present study
the cell-viability results showed an obvious decrease of living
cells in DCM/F7 treated group. These cells had typical
morphological changes associated with apoptosis such as
chromatin condensation, DNA fragmentation, membrane
blebbing and apoptotic body formation as observed under
ﬂuorescence microscopy on AO/PI staining. It is well known
that, in apoptosis, the earliest recognized morphological
changes are compaction and segregation of the nuclear
chromatin, with the result of chromatin margination and
condensation of the cytoplasm [30]. Progression of the
condensation is accompanied by convolution of the nuclear
and cell outlines followed by breaking up of the nucleus into
discrete fragments and by budding of the cell as a whole8 Evidence-Based Complementary and Alternative Medicine
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Figure 5: SEM micrographs of surface ultrastructural characteristics of CEMss cells treated with DCM/F7 in a time-dependent manner
(24 and 48h) and cultured in RPMI 1640 media maintained at 37◦Ca n d5 %C O 2. (a) The characteristic of untreated CEMss cells surface
showing the restoration of a typical morphological feature of a cancer cell such as smooth surface (as shown in white arrow). (b) and (c)
DCM/F7treatedCEMsscells(24and48;IC50:3μg/ml)showeddistinctmorphologicalchangescorrespondingtotypicalapoptosis,including
cell shrinkage and membrane blebbing and separated apoptotic bodies (magniﬁcation 4000x). BL: Blebbing; AB: Apoptotic body.
to produce membrane-bounded apoptotic bodies [31]. The
cellular events in apoptosis are accomplished very fast,
with only a few minutes elapsing between the onset of the
process and the cluster formation of apoptotic bodies. In
thisstudy,SEMwasemployedtoobtaindetailedinformation
about the cell surface of CEMss and ultrastructural changes
were studied using TEM. The SEM electron micrograph of
currentinvestigationshoweddistinctmorphologicalchanges
corresponding to a typical cellular surface morphology of
apoptosis, including cell shrinkage, membrane blebbing and
formation of apoptotic bodies after treatment. In addition,
the TEM observation of treated cell nuclear chromatin
marginization, chromatin condensation and formation of
vacuoles characterize the apoptosis cell. Besides this, treated
cells (CEMss) demonstrate the condensed cristae of mito-
chondria as a typical morphological feature in apoptosis.
In contrast, the untreated cell’s nucleus contains evenly
distributed chromatin and a large nucleolus, mitochondria
are large and numerous, rough endoplasmic reticulum,
ribosome and the double membrane nuclear envelops are
also seen.
Apoptosis is an active physiological process resulting in
cellular self-destruction that involves speciﬁc morphological
and biochemical changes in the nucleus and cytoplasm.
Apoptosis is regulated by two major pathways: the extrin-
sic (receptor mediated) and the intrinsic (mitochondrial
mediated) pathways. Due to the sensitivity of the intrinsic
pathway, tumors arise more often through this pathway than
the extrinsic pathway [32]. In both ways apoptotic endonu-
cleases degrade chromosomal DNA during programmed cell
death. The cleavage of nuclear DNA into nucleosome-sized
fragments is a signature of apoptosis. Because such cleavage
degrades the genetic materials that are crucial for producing
cellularproteins,DNAfragmentationarguablyrepresentsthe
most severe damage to the cell [33]. In the present study the
TUNEL assay revealed apoptotic induction in CEMss cells
e x p o s e dt oD C M / F 73μgml −1 (IC50)a td i ﬀerent time point.
Similar kind of observations were noted previously when a
fraction from DCM extract of this plant induces apoptosis
by colorimetric TUNEL assay [4].
The presence of high concentrations of unsaturated
aliphatic compounds was clearly evident with most of
the identiﬁed phytochemicals. This linoleic acid-enriched
fraction focusing in to the importance of health supplements
which could be act as a drug or prevent the occurrence of
malignancies. It is known that high concentration of certain
fatty acids can cause cell death via apoptosis or necrosis
[34]. Linoleic acid [35–38]a sw e l la sc o n j u g a t e dl i n o l e i c
acid was well documented for its apoptotic eﬀect [39–42]. In
addition, Yoo et al. [43] isolated three fatty acids including
hexadecanoic acid which has been proven to be a promising
anticancer agent to exert apoptosis mediated by caspase-3
activation. Furthermore, the involvement of hexadecanoic
acid has been evidenced in the mitochondrial cyclosporin
A-insensitive pore induced by Pal/Ca2+ complexes in the
apoptotic process [44] and Fas-mediated apoptosis in PC12Evidence-Based Complementary and Alternative Medicine 9
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Figure 6: Electromicrograph of untreated human T4 lymphoblastoid leukemia cells (CEMss) demonstrates the normal structure of CEMss
cancer cell. The nucleus (N) contains evenly distributed chromatin and a large nucleolus (Nu), mitochondria (M) are large and numerous,
rough endoplasmic reticulum (RER), ribosome (R) and the double membrane nuclear envelop (arrow) are also seen (×1000). In the treated
cell nuclear chromatin marginisation (b-cm) (×1500), chromatin condensation (c-cc) (×1500) formation of apoptosis micronuclei (b-mn)
characterize the apoptosis cell. The vacuolization (v) is also seen. Mitochondria of the control cell (a-m) shows more or less parallel cristae
and of a treated cell (c-m) show vacuolization and loss of cristae. Cells were cultured in RPMI 1640 (25 ml ﬂask) media maintained at 37◦C
and 5% CO2.
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Figure 7: Apo Brdu-TUNEL assay showing the eﬀect of 48 h exposure of CEMss to 3μg/ml DCM/F7. The x-axis of the density plots shows
relative DNA content, while y-axis shows the relative number of strand break within individual cells. (a) Control 48 h (n = 2) and (a) CEMss
cells exposed to 3 μg/ml DCM/F7 (n = 2 for each experiments).10 Evidence-Based Complementary and Alternative Medicine
Table 3: Chemical composition of DCM/F7
Pick no Relative retention time (min) Componenta Relative percentageb (%)
1 9.548 2-Heptinal 0.43 ± 0.03
2 11.729 2-octenal 0.14 ± 0.01
3 12.342 Decane 0.12 ± 0.01
4 14.294 Decane Derivative 0.12 ± 0.02
5 15.665 2-Decenal 0.14 ± 0.01
6 16.282 2,4-Decadienal derivative 0.11 ± 0.01
7 16.73 2,4-Decadienal 0.19 ± 0.02
8 18.245 Vanillin 0.09 ± 0.01
9 20.723 Undecanoic acid 0.49 ± 003
10 22.842 Hexadecanal 0.06 ± 0.01
11 23.032 Tetradecanoic acid derivative 0.15 ± 0.02
12 23.625 Tetradecanoic acid 0.6 ± 0.04
13 23.789 Pentadecanoic acid, methyl ester 0.06 ± 0.01
14 24.254 Hexadecanal 0.09 ± 0.01
15 24.608 Pentadecanoic acid derivative 2.44 ± 0.1
16 24.871 9-Hexadecen-1-ol 0.31 ± 0.03
17 25.013 Pentadecanoic acid 0.54 ± 0.04
18 25.128 1-Tetradecanol 0.42 ± 0.03
19 25.377 9-Hexadecanoic acid 0.12 ± 0.01
20 25.642 Hexadecanoic acid, methyl ester 0.41 ± 0.02
21 26.262 9-Hexadecanoic acid derivative 6.99 ± 0.08
22 26.785 n-Hexadecanoic acid 17.89 ± 0.1
23 27.041 cis-2-Methyl-7-octadecene 1.99 ± 0.09
24 27.398 Oleic acid 1.49 ± 0.08
25 27.608 Heptadecanoic acid 0.41 ± 0.01
26 27.804 9,12-Octadecadienoic acid, methyl ester 0.79 ± 0.01
27 27.877 11,14,17-Eicosatrienoic acid, methyl ester 0.56 ± 0.01
28 29.199 9,12-Octadecadienoic acid 51.2 ± 0.52
29 44.199 5-Cholestene-3-ol, 24-methyl 1.94 ± 0.08
30 45.232 Stigmasta-5,22-dien-3-ol 6.06 ± 0.07
aComponents were identiﬁed by the comparison of each retention time with authentic standards or diagnosed by the mass spectral databases from
NIST/EPA/NIH mass special database library of the GC-MS system, at least with a library ﬁt factor >90%.
bArea percentage of individual proﬁles was used as the relative content of the corresponding components. Values are mean ± SD of triplicate determinations.
cells [45]. The rich presence of linoleic acid and its speciﬁcity
towards cancer cells is in well agreement with the previous
studies which demonstrated that dietary conjugated linoleic
acid could induce apoptosis of p53 wild-type pre-neoplastic
lesions in the rat mammary gland, but not of the normal
mammary epithelium [46]. Based on these literatures it can
be proposed that the presence of both linoleic acid and
hexadecanoic acid might be responsible for the apoptotic
eﬀect produced by DCM/F7 on CEMss.
Natural agents that restrain the proliferation of malig-
nant cells by inducing apoptosis may represent a useful
mechanistic approach to both cancer chemoprevention and
chemotherapy. Thus, there is growing attention in the use of
plant materials for the treatment of various cancers and the
development of safer and more eﬀective therapeutic agents
[47]. Due to additive or synergistic eﬀects, and competing
or confounding eﬀects of plant extracts [48], comparison of
these eﬀects on well-characterized tumor cell lines provide
an outline and model for the discussion and analysis of
possible biological mechanisms that produce clinical eﬀects
[49, 50]. Similar kind of studies has aided to identify
chemotherapeuticagentsthatprovideselectiveeﬀectsagainst
cancerous cells without untoward eﬀects on normal cells
[51]. Our study demonstrates that the DCM/F7 fraction of
T. ﬂagelliforme inhibited leukemia cancer-cell proliferation
selectively, via the induction of apoptosis. Apoptosis is a
highly regulated and organized cell death process controlling
the development and homeostasis of multicellular organisms
that occur under a variety of physiological and pathological
conditions, which is characterized by a number of well-
deﬁned features including cellular morphological change,
chromatin condensation and oligonucleosomal DNA cleav-
age [52]. Our results were shown to be due to apoptosis by
the demonstration of the morphological characteristics of
apoptosis and the observation of cells containing fragmented
nuclei and DNA (Figure 8).TheseresultsindicateclearlythatEvidence-Based Complementary and Alternative Medicine 11
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Figure 8: The hypothetical diagram demonstrating the possible
apoptotic eﬀect of the DCM/F7 of T. ﬂagelliforme in leukemia in
vitro.
T. ﬂagelliforme which has been used as a healthcare supple-
ment as well as traditional medicine acts via programmed
cell death. In addition, our results emphasize important
health beneﬁts of health supplements and herbs containing
fatty acids. Additional studies are needed to determine the
molecular mechanisms and its pathways of the selected
fractionalongwithitsactivecomponentsandtoevaluatethis
potential anticancer activity in vivo.
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